Home » Education hub » BioProcess International 2025
We are excited to join the 2025 BioProcess International Conference, a premier event that gathers today’s top scientists from across the entire spectrum of biopharmaceutical development and production.
Take this opportunity to connect with our delegates and explore our comprehensive range of services. Our CMC experts help clients navigate the complex demands of product development and we support strategic activities in areas like manufacturing and operations, process development and optimization, CDMO selection, quality and regulatory affairs, and more.
In this 1st article of the series, we explore three common reasons why pharmaceutical development companies might consider engaging a CDMO.
In this 2nd article of the series, we detail the best practices for working with a CDMO to ensure the success of your product development.
In this 3rd article of the series, we focus on evaluating identified CDMOs and review the most important factors in creating a successful sponsor-CDMO relationship.
In this 4th article in the series, we explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
In the 5th and final article of the series, we answer why analytical method development is an important component of your biologics and which CQAs affect product performance and stability.
Subscribe to our newsletter for the latest news, events, and thought leadership